Strategic combination

06/28/2023 - 22:05

Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM
06/26/2023 - 22:00

ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
05/23/2023 - 22:37

Exemption document in connection with the merger by absorption of Pherecydes Pharma by Erytech Pharma
05/17/2023 - 14:00

Notice of the proposed Merger
05/16/2023 - 20:30

Report of the Merger Auditor on the value of the contributions (French only)
05/16/2023 - 20:30

Report of the Merger Auditor on the remuneration of the contributions (French only)
02/17/2023 - 22:30

€1.5m capital increase reserved to the historical shareholders
02/16/2023 - 14:30

Presentation of the Strategic Combination Project
02/15/2023 - 22:40

ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies